Modelled DT Structure
Method: loop building
Template PDB: 5XJY_A
Identity: 100%
Minimized Score: -1973.407 kcal/mol
Detail: Structure Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0036 | ||||
Gene Name | ABCA1 | ||||
Protein Name | ATP-binding cassette sub-family A member 1 | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Modelled DT Structure Method: loop building Template PDB: 5XJY_A Identity: 100% Minimized Score: -1973.407 kcal/mol Detail: Structure Info |
||||
Synonyms | ABC-1; ABC1; ABCA1; ATP-binding cassette 1; ATP-binding cassette transporter 1; CERP; Cholesterol efflux regulatory protein; HDLDT1; TGD | ||||
DT Family | ATP-Binding Cassette (ABC) Superfamily | ||||
Cholesterol/Phospholipid/Retinal (CPR) Flippase Family (ABCA) | |||||
Tissue Specificity | Widely expressed, but most abundant inmacrophages. | ||||
Function | This transporter is cAMP-dependent and sulfonylurea-sensitive. Involved in the efflux of intracellular cholesterol and phospholipids and their transfer to apoliproteins to form nascent high density lipoproteins/HDLs. | ||||
Endogenous Substrate(s) | Lipids | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(α) Microbiota Influence of This DT |
|||||
(β) Post-translational Modification of This DT |
|||||
(γ) Transcriptional Regulation of This DT |
|||||
(δ) Epigenetic Regulation of This DT |
|||||
(ε) Exogenous Modulation of This DT |
|||||
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
(α) Mutation-induced Structural Variation |
|||||
(β) Inter-species Structural Differences |
|||||
(γ) Outward/inward-facing Conformation |
|||||
General Variability Data of This DT (VARIDT 1.0) |
|||||
(α) Genetic Polymorphisms of This DT |
|||||
(β) Disease-specific Protein Abundances of This DT |
|||||
(γ) Species- and Tissue-specific DT Abundances |
|||||
Molecular Transporting Profile of This DT | |||||
Full List of Drug(s) Transported by This DT |
|||||
Approved Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
Fenofibric acid
|
Approved | Drug Info | Hypercholesterolemia | 5C80.0 | [1] |
Clinical Trial Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
Cholesterol
|
Phase 2 | Drug Info | Cone-Rod dystrophy | 9B70 | [2] |
References | |||||
1 | Fenofibric acid, an active form of fenofibrate, increases apolipoprotein A-I-mediated high-density lipoprotein biogenesis by enhancing transcription of ATP-binding cassette transporter A1 gene in a liver X receptor-dependent manner. Arterioscler Thromb Vasc Biol. 2005 Jun;25(6):1193-7. | ||||
2 | ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions. J Lipid Res. 2003 Jul;44(7):1373-80. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.